IL103710A - R(-)-enantiomers of n-trityl- 4-oxo-5-phosphonovalinate derivatives - Google Patents

R(-)-enantiomers of n-trityl- 4-oxo-5-phosphonovalinate derivatives

Info

Publication number: IL103710A
Authority: IL; Israel
Prior art keywords: oxo; derivatives; phosphononorvaline; formula; trityl
Prior art date: 1991-11-15

Application number

IL103710A

Other languages

English (en)

Other versions

IL103710A0 (en

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-15

Filing date

1992-11-11

Publication date

1998-02-08

1992-11-11 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1993-04-04 Publication of IL103710A0 publication Critical patent/IL103710A0/xx

1998-02-08 Publication of IL103710A publication Critical patent/IL103710A/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Neurosurgery (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IL103710A 1991-11-15 1992-11-11 R(-)-enantiomers of n-trityl- 4-oxo-5-phosphonovalinate derivatives IL103710A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US79283491A	1991-11-15	1991-11-15

Publications (2)

Publication Number	Publication Date
IL103710A0 IL103710A0 (en)	1993-04-04
IL103710A true IL103710A (en)	1998-02-08

Family

ID=25158215

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL103710A IL103710A (en)	1991-11-15	1992-11-11	R(-)-enantiomers of n-trityl- 4-oxo-5-phosphonovalinate derivatives

Country Status (16)

Country	Link
EP (1)	EP0613459B1 (de)
JP (1)	JP3168563B2 (de)
KR (1)	KR100241480B1 (de)
AT (1)	ATE134989T1 (de)
AU (1)	AU667845B2 (de)
CA (1)	CA2121835A1 (de)
DE (1)	DE69208888T2 (de)
DK (1)	DK0613459T3 (de)
ES (1)	ES2087555T3 (de)
FI (1)	FI942248A0 (de)
GR (1)	GR3019587T3 (de)
HU (1)	HU214055B (de)
IL (1)	IL103710A (de)
MX (1)	MX9206448A (de)
NO (1)	NO305314B1 (de)
WO (1)	WO1993010075A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2025326C (en) *	1989-09-19	2001-04-24	Jeffrey P. Whitten	Nmda antagonists

1992
- 1992-10-13 FI FI942248A patent/FI942248A0/fi unknown
- 1992-10-13 KR KR1019940701634A patent/KR100241480B1/ko not_active Expired - Fee Related
- 1992-10-13 CA CA002121835A patent/CA2121835A1/en not_active Abandoned
- 1992-10-13 WO PCT/US1992/008739 patent/WO1993010075A1/en not_active Ceased
- 1992-10-13 DE DE69208888T patent/DE69208888T2/de not_active Expired - Fee Related
- 1992-10-13 HU HU9401469A patent/HU214055B/hu not_active IP Right Cessation
- 1992-10-13 AT AT92921774T patent/ATE134989T1/de not_active IP Right Cessation
- 1992-10-13 ES ES92921774T patent/ES2087555T3/es not_active Expired - Lifetime
- 1992-10-13 JP JP50924593A patent/JP3168563B2/ja not_active Expired - Fee Related
- 1992-10-13 EP EP92921774A patent/EP0613459B1/de not_active Expired - Lifetime
- 1992-10-13 DK DK92921774.3T patent/DK0613459T3/da active
- 1992-10-13 AU AU28642/92A patent/AU667845B2/en not_active Ceased
- 1992-11-10 MX MX9206448A patent/MX9206448A/es not_active IP Right Cessation
- 1992-11-11 IL IL103710A patent/IL103710A/en not_active IP Right Cessation
1994
- 1994-05-13 NO NO941820A patent/NO305314B1/no not_active IP Right Cessation
1996
- 1996-04-09 GR GR960400979T patent/GR3019587T3/el unknown

Also Published As

Publication number	Publication date
HU9401469D0 (en)	1994-08-29
ATE134989T1 (de)	1996-03-15
EP0613459B1 (de)	1996-03-06
DE69208888D1 (de)	1996-04-11
ES2087555T3 (es)	1996-07-16
AU2864292A (en)	1993-06-15
KR100241480B1 (ko)	2000-03-02
IL103710A0 (en)	1993-04-04
JP3168563B2 (ja)	2001-05-21
NO941820L (no)	1994-05-13
FI942248A7 (fi)	1994-05-13
FI942248L (fi)	1994-05-13
FI942248A0 (fi)	1994-05-13
DK0613459T3 (da)	1996-04-01
HUT70551A (en)	1995-10-30
NO941820D0 (no)	1994-05-13
DE69208888T2 (de)	1996-08-01
JPH07501523A (ja)	1995-02-16
HU214055B (en)	1997-12-29
AU667845B2 (en)	1996-04-18
NO305314B1 (no)	1999-05-10
CA2121835A1 (en)	1993-05-27
GR3019587T3 (en)	1996-07-31
MX9206448A (es)	1993-05-01
WO1993010075A1 (en)	1993-05-27
EP0613459A1 (de)	1994-09-07

Similar Documents

Publication	Publication Date	Title
JP5117493B2 (ja)	2013-01-16	ヒンバシン類似体の合成において使用される｛［５−（３−フルオロフェニル）−ピリジン−２−イル］メチル｝ホスホン酸ジエチルの合成
JP5146965B2 (ja)	2013-02-20	不純物を含まない非晶質ロスバスタチンカルシウムの調製方法
RU2618223C2 (ru)	2017-05-03	Новые способы получения простагландинамидов
US6600025B1 (en)	2003-07-29	Intermediates, process for preparing macrolide antibiotic agent therefrom
KR100926844B1 (ko)	2009-11-13	스핑고신의 합성을 위한 제조방법
AU2021207775B2 (en)	2025-12-11	Methods, processes and intermediates for preparing chroman compounds
JP2716746B2 (ja)	1998-02-18	ホスフィン酸類
EP0613459B1 (de)	1996-03-06	N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten
JP2010508376A (ja)	2010-03-18	ビホスホン酸、及びその塩の製造方法
US5554773A (en)	1996-09-10	N-trityl protected aspartic acid derivatives for the preparation of phosphonate NMDA antagonists
JPS5936914B2 (ja)	1984-09-06	セフアロスポリン類縁体
RU2205834C2 (ru)	2003-06-10	Способ получения [2-((8,9)-диоксо-2,6-диазобицикло-[5.2.0]нон-1(7)-ен-2-ил)этил]фосфоновой кислоты, способ получения ди-с1-с6-алкилового эфира n-[3-(трет-бутилоксикарбониламино)пропил]-2-аминоэтилфосфорной кислоты, соединения
KR101195631B1 (ko)	2012-10-30	９-［２-(포스포노메톡시)에틸］아데닌의 개선된 제조방법
JP3157262B2 (ja)	2001-04-16	新規オキサゾリジノン誘導体
JP4070608B2 (ja)	2008-04-02	光学的に活性なジヒドロピロンの製造方法
JP2978590B2 (ja)	1999-11-15	エチレンジアミン二酢酸化合物及びその製造法
KR100472048B1 (ko)	2005-03-08	아즈트레오남의 신규제조방법
EP1673377B1 (de)	2013-12-25	Verfahren zur herstellung von 3-amino-2-hydroxypropylphosphinsäurederivaten
JP3185946B2 (ja)	2001-07-11	γ，δ−不飽和−β−アミノ酸誘導体及びその製造方法
JP3494465B2 (ja)	2004-02-09	光学活性α−アミノ酸誘導体の製造方法
JP3719269B2 (ja)	2005-11-24	２−アルキル−４−オキソ−５、６、７、８−テトラヒドロ−シクロヘプトイミダゾールの製造方法
US20020165269A1 (en)	2002-11-07	Process for preparing optically active dihydropyrones
JPH08119981A (ja)	1996-05-14	イミドビスリン酸、その製造方法およびその使用
JPH09241266A (ja)	1997-09-16	ビス−テトラヒドロフラン誘導体の製造方法
CZ2012978A3 (cs)	2014-07-09	Lipofilní analogy chráněných aminoalkylsubstituovaných glycinů a způsob jejich přípravy

Legal Events

Date	Code	Title	Description
1998-07-15	FF	Patent granted
1999-01-26	KB	Patent renewed
2003-07-31	RH1	Patent not in force
2006-09-05	HC	Change of name of proprietor(s)	Owner name: AVENTIS INC. Free format text: FORMER NAME:MERRELL PARMACEUTICALS, INC.